Annual SGA
$13.88 M
-$175.00 K-1.24%
December 31, 2023
Summary
- As of February 6, 2025, CADL annual SGA is $13.88 million, with the most recent change of -$175.00 thousand (-1.24%) on December 31, 2023.
- During the last 3 years, CADL annual SGA has risen by +$8.70 million (+168.00%).
- CADL annual SGA is now -1.24% below its all-time high of $14.06 million, reached on December 31, 2022.
Performance
CADL SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly SGA
$3.34 M
-$251.00 K-6.99%
September 30, 2024
Summary
- As of February 6, 2025, CADL quarterly SGA is $3.34 million, with the most recent change of -$251.00 thousand (-6.99%) on September 30, 2024.
- Over the past year, CADL quarterly SGA has dropped by -$251.00 thousand (-6.99%).
- CADL quarterly SGA is now -19.76% below its all-time high of $4.16 million, reached on March 31, 2023.
Performance
CADL Quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM SGA
-$627.89 M
-$52.20 M-9.07%
September 30, 2024
Summary
- As of February 6, 2025, CADL TTM SGA is -$627.89 million, with the most recent change of -$52.20 million (-9.07%) on September 30, 2024.
- Over the past year, CADL TTM SGA has dropped by -$641.36 million (-4762.13%).
- CADL TTM SGA is now -1321.51% below its all-time high of -$44.17 million.
Performance
CADL TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Selling, General & Administrative Expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
CADL Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -1.2% | -7.0% | -4762.1% |
| 3 y3 years | +168.0% | +5.7% | -4566.5% |
| 5 y5 years | +443.4% | +5.7% | -4566.5% |
CADL Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -1.2% | +30.1% | -19.8% | +10.8% | -127.0% | at low |
| 5 y | 5-year | -1.2% | +443.4% | -19.8% | +358.9% | -1321.5% | at low |
| alltime | all time | -1.2% | +443.4% | -19.8% | +358.9% | -1321.5% | at low |
Candel Therapeutics Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $3.34 M(-7.0%) | $13.79 M(+2.4%) |
| Jun 2024 | - | $3.59 M(-5.5%) | $13.47 M(-0.4%) |
| Mar 2024 | - | $3.80 M(+24.2%) | $13.52 M(-2.6%) |
| Dec 2023 | $13.88 M(-1.2%) | $3.06 M(+1.5%) | $13.88 M(-0.7%) |
| Sep 2023 | - | $3.02 M(-17.3%) | $13.98 M(-3.6%) |
| Jun 2023 | - | $3.65 M(-12.5%) | $14.51 M(-0.8%) |
| Mar 2023 | - | $4.16 M(+31.8%) | $14.62 M(+4.0%) |
| Dec 2022 | $14.06 M | $3.16 M(-10.6%) | $14.06 M(-5.1%) |
| Sep 2022 | - | $3.54 M(-6.0%) | $14.81 M(+5.3%) |
| Jun 2022 | - | $3.76 M(+4.5%) | $14.07 M(+13.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | $3.60 M(-8.1%) | $12.35 M(+15.6%) |
| Dec 2021 | $10.67 M(+106.0%) | $3.92 M(+40.1%) | $10.69 M(+13.8%) |
| Sep 2021 | - | $2.79 M(+37.0%) | $9.39 M(+24.2%) |
| Jun 2021 | - | $2.04 M(+5.4%) | $7.56 M(+18.6%) |
| Mar 2021 | - | $1.94 M(-26.2%) | $6.38 M(+23.3%) |
| Dec 2020 | $5.18 M(+102.8%) | $2.62 M(+171.1%) | $5.17 M(+102.8%) |
| Sep 2020 | - | $967.00 K(+13.1%) | $2.55 M(+61.1%) |
| Jun 2020 | - | $855.00 K(+17.4%) | $1.58 M(+117.4%) |
| Mar 2020 | - | $728.00 K | $728.00 K |
| Dec 2019 | $2.56 M | - | - |
FAQ
- What is Candel Therapeutics annual SGA?
- What is the all time high annual SGA for Candel Therapeutics?
- What is Candel Therapeutics annual SGA year-on-year change?
- What is Candel Therapeutics quarterly SGA?
- What is the all time high quarterly SGA for Candel Therapeutics?
- What is Candel Therapeutics quarterly SGA year-on-year change?
- What is Candel Therapeutics TTM SGA?
- What is the all time high TTM SGA for Candel Therapeutics?
- What is Candel Therapeutics TTM SGA year-on-year change?
What is Candel Therapeutics annual SGA?
The current annual SGA of CADL is $13.88 M
What is the all time high annual SGA for Candel Therapeutics?
Candel Therapeutics all-time high annual SGA is $14.06 M
What is Candel Therapeutics annual SGA year-on-year change?
Over the past year, CADL annual SGA has changed by -$175.00 K (-1.24%)
What is Candel Therapeutics quarterly SGA?
The current quarterly SGA of CADL is $3.34 M
What is the all time high quarterly SGA for Candel Therapeutics?
Candel Therapeutics all-time high quarterly SGA is $4.16 M
What is Candel Therapeutics quarterly SGA year-on-year change?
Over the past year, CADL quarterly SGA has changed by -$251.00 K (-6.99%)
What is Candel Therapeutics TTM SGA?
The current TTM SGA of CADL is -$627.89 M
What is the all time high TTM SGA for Candel Therapeutics?
Candel Therapeutics all-time high TTM SGA is -$44.17 M
What is Candel Therapeutics TTM SGA year-on-year change?
Over the past year, CADL TTM SGA has changed by -$641.36 M (-4762.13%)